2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Insurance Revenue | 4,961,000 | 8.059% | 9,371,000 | 8,549,000 | -- | -- |
Interest Income | -- | -- | 340,000 | 237,000 | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | -- | 24,217,000 | 42,521,000 |
Net Premium Income | -- | -- | -- | -- | 22,373,000 | 10,312,000 |
Investment Income/(Loss) | 2,495,000 | -65.207% | 9,423,000 | (29,617,000) | 3,486,000 | 44,991,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | -- | -- |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | -- | -- |
Other Income/(Loss) | 197,000 | 11.932% | 369,000 | 558,000 | 641,000 | 670,000 |
Total Revenues | 7,653,000 | -35.894% | 19,503,000 | (20,273,000) | 26,500,000 | 55,973,000 |
Insurance Service Expenses | (3,638,000) | 4.271% | (7,113,000) | (6,267,000) | -- | -- |
Net Expenses from Reinsurance Contracts | (252,000) | 203.614% | (171,000) | (105,000) | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | -- | -- | (8,839,000) | 28,623,000 | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | (2,274,000) | -64.994% | 191,000 | (1,193,000) | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (740,000) | 33.574% | (1,208,000) | (1,219,000) | (23,834,000) | (54,071,000) |
Other Non-operating Items | -- | -- | -- | -- | -- | -- |
Share of results of Associates & JCEs | (243,000) | 232.877% | (91,000) | (85,000) | 352,000 | 517,000 |
Profit / (Loss) before Taxation | 506,000 | -59.292% | 2,272,000 | (519,000) | 3,018,000 | 2,419,000 |
Taxation | (324,000) | 9.459% | (560,000) | (478,000) | (804,000) | (234,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | (5,027,000) | -- |
Non-controlling Interests | (62,000) | 1966.667% | (11,000) | (10,000) | 771,000 | (67,000) |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 120,000 | -87.288% | 1,701,000 | (1,007,000) | (2,042,000) | 2,118,000 |
2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Depreciation & Amortisation | -- | -- | 524,000 | 494,000 | 830,000 | 383,000 |
Directors' Emoluments | -- | -- | 16,859 | 17,385 | 17,492 | 18,285 |
2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
EPS (cts) | 4.400 | -87.246% | 62.100 | -36.800 | -77.700 | 81.600 |
DPS (cts) | 6.840 | -- | 20.470 | 18.780 | 17.230 | 16.100 |
Dividend Payout Ratio (%) | 155.455% | -- | 32.963% | -- | -- | 19.730% |
Cash flow per share ($) | -- | -- | 0.304 | 0.394 | (0.055) | 0.757 |
NBV per share ($) | 5.884 | -- | 6.473 | 6.085 | 6.222 | 8.001 |
Remarks: | Real time quote last updated: 15/11/2024 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders ($) | USD 120,000,000 |
%Change | -87.288% |
EPS / (LPS) | USD 0.044 |
NBV Per Share ($) | USD 5.884 |